John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking GLP-1s would come in with significant tendon injuries from relatively minor ...

GLP-1 receptor agonist use in adults with concurrent type 2 diabetes and obesity was associated with increased risk for ...

New world champion Torrie Lewis is on a collision course to face the drug cheat who initially denied her gold after seven ...

HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Innorna, a clinical--stage biotech company advancing RNA medicines, today announced that the U.S. Food and ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

IN026 is a potential first-in-class mRNA therapy for refractory gout, marking the emergence of a new category of mRNA medicines enabled by Innorna's proprietary mRNA-LNP platform.HONG KONG SAR ...

A medication commonly used to treat gout could be the key to reducing a cardiovascular condition that puts one in five people aged over 75 at risk of ...

HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Innorna, a clinical‑stage biotech company advancing RNA medicines, today announced that the U.S. Food and ...

Gout is the most common inflammatory arthritis affecting 1-2% of the population. It is a very common problem presenting to ...

Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio® ...

Australia’s Torrie Lewis has been retrospectively awarded a U20 World Athletics Championships gold medal after it emerged the winner of that race had tested positive for banned substances.

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipat ...